Revelation BiosciencesREVB
13F holders, Q2 2026 (June 30)11holders
4new positions
3sold out
1famous investor
$1.03avg. 13F price*
At the end of Q2 2026, 11 institutions reported holding Revelation Biosciences Inc. (REVB) in their 13F filings, unchanged from Q1 2026. 4 opened new positions and 3 sold out. The largest holders were Sabby Management, LLC ($217K), Citadel Advisors ($40K) and Geode Capital Management, LLC ($18K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Revelation Biosciences Inc.
- CUSIP
- 76135L804
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $57K |
| Exits | 3 | $406K |
All 13F filers, Q1 2026 → Q2 2026: 169,329 shares bought and 364,744 shares sold, net −195,415 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Sabby Management, LLC | 1.83% | Add +111.8% | 210,582 | $217K |
| Citadel Advisors | 0.00% | New | 38,579 | $40K |
| Geode Capital Management, LLC | 0.00% | Reduce -60.2% | 17,192 | $18K |
| HRT Financial LP | 0.00% | New | 16,978 | $17K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 13,127 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +60.2% | 6,528 | $7K |
| Royal Bank of Canada | 0.00% | No change | 747 | $1K |
| SBI Securities Co., Ltd. | 0.00% | No change | 344 | $354 |
| Barclays PLC | 0.00% | New | 168 | $173 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | No change | 9 | $9 |
| Caitong International Asset Management Co., Ltd | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is REVB's weight in each manager's 13F, not the share of Revelation Biosciences Inc. the manager owns.